Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
Background: More and more studies are focusing on the adverse effects and damage caused by PPI abuse, we carried out a systematic review and meta-analysis for assessing whether the proton pump inhibitor (PPI) leads to hepato-biliary-pancreatic cancer.Methods: PubMed, EMBASE and Web of Science were s...
Saved in:
Main Authors: | Wence Zhou (Author), Xinlong Chen (Author), Qigang Fan (Author), Haichuan Yu (Author), Wenkai Jiang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Age-period-cohort analysis of pancreatitis epidemiological trends from 1990 to 2019 and forecasts for 2044: a systematic analysis from the Global Burden of Disease Study 2019
by: Wenkai Jiang, et al.
Published: (2023) -
Research trends on immunotherapy for pancreatic cancer: A bibliometric analysis
by: Jubao Niu, et al.
Published: (2023) -
Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030
by: Ru He, et al.
Published: (2024) -
Cross-country health inequalities of four common nutritional deficiencies among children, 1990 to 2019: data from the Global Burden of Disease Study 2019
by: Wenkai Jiang, et al.
Published: (2024) -
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders
by: Federica Di Vincenzo, et al.
Published: (2023)